array:25 [
  "pii" => "S0001731021002854"
  "issn" => "00017310"
  "doi" => "10.1016/j.ad.2020.01.020"
  "estado" => "S300"
  "fechaPublicacion" => "2022-01-01"
  "aid" => "2718"
  "copyright" => "AEDV"
  "copyrightAnyo" => "2021"
  "documento" => "article"
  "crossmark" => 1
  "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
  "subdocumento" => "sco"
  "cita" => "Actas Dermosifiliogr. 2022;113:86-8"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:1 [
    "total" => 0
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S0001731022000199"
    "issn" => "00017310"
    "doi" => "10.1016/j.ad.2020.01.021"
    "estado" => "S300"
    "fechaPublicacion" => "2022-01-01"
    "aid" => "2881"
    "copyright" => "AEDV"
    "documento" => "article"
    "crossmark" => 1
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "sco"
    "cita" => "Actas Dermosifiliogr. 2022;113:T86-T88"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:1 [
      "total" => 0
    ]
    "en" => array:10 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Resident&#8217;s Forum</span>"
      "titulo" => " RF - New Drugs for Managing Acne"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "T86"
          "paginaFinal" => "T88"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "FR - Nuevos f&#225;rmacos para el manejo del acn&#233;"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "F&#46; Alamon-Reig, M&#46;C&#46; Bois, D&#46; Morgado-Carrasco"
          "autores" => array:3 [
            0 => array:2 [
              "nombre" => "F&#46;"
              "apellidos" => "Alamon-Reig"
            ]
            1 => array:2 [
              "nombre" => "M&#46;C&#46;"
              "apellidos" => "Bois"
            ]
            2 => array:2 [
              "nombre" => "D&#46;"
              "apellidos" => "Morgado-Carrasco"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731022000199?idApp=UINPBA000044"
    "url" => "/00017310/0000011300000001/v2_202202160543/S0001731022000199/v2_202202160543/en/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S0001731021002799"
    "issn" => "00017310"
    "doi" => "10.1016/j.ad.2020.05.013"
    "estado" => "S300"
    "fechaPublicacion" => "2022-01-01"
    "aid" => "2712"
    "documento" => "article"
    "crossmark" => 1
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "sco"
    "cita" => "Actas Dermosifiliogr. 2022;113:T85"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:1 [
      "total" => 0
    ]
    "es" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">IM&#193;GENES EN DERMATOLOG&#205;A</span>"
      "titulo" => " Aplasia cutis cong&#233;nita asociada a trisom&#237;a 13"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "paginas" => array:1 [
        0 => array:1 [
          "paginaInicial" => "T85"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "Aplasia Cutis Congenita Associated with Trisomy 13"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:6 [
          "identificador" => "fig0005"
          "etiqueta" => "Figura 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 681
              "Ancho" => 905
              "Tamanyo" => 127494
            ]
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "J&#46; Mart&#237;nez-Coronado, Y&#46; Chong-Cazares"
          "autores" => array:2 [
            0 => array:2 [
              "nombre" => "J&#46;"
              "apellidos" => "Mart&#237;nez-Coronado"
            ]
            1 => array:2 [
              "nombre" => "Y&#46;"
              "apellidos" => "Chong-Cazares"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S1578219021003176"
        "doi" => "10.1016/j.adengl.2021.11.013"
        "estado" => "S200"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219021003176?idApp=UINPBA000044"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731021002799?idApp=UINPBA000044"
    "url" => "/00017310/0000011300000001/v2_202202160543/S0001731021002799/v2_202202160543/es/main.assets"
  ]
  "asociados" => array:1 [
    0 => array:19 [
      "pii" => "S0001731022000199"
      "issn" => "00017310"
      "doi" => "10.1016/j.ad.2020.01.021"
      "estado" => "S300"
      "fechaPublicacion" => "2022-01-01"
      "aid" => "2881"
      "copyright" => "AEDV"
      "documento" => "article"
      "crossmark" => 1
      "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
      "subdocumento" => "sco"
      "cita" => "Actas Dermosifiliogr. 2022;113:T86-T88"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:1 [
        "total" => 0
      ]
      "en" => array:10 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Resident&#8217;s Forum</span>"
        "titulo" => " RF - New Drugs for Managing Acne"
        "tienePdf" => "en"
        "tieneTextoCompleto" => "en"
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "T86"
            "paginaFinal" => "T88"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "es" => array:1 [
            "titulo" => "FR - Nuevos f&#225;rmacos para el manejo del acn&#233;"
          ]
        ]
        "contieneTextoCompleto" => array:1 [
          "en" => true
        ]
        "contienePdf" => array:1 [
          "en" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "F&#46; Alamon-Reig, M&#46;C&#46; Bois, D&#46; Morgado-Carrasco"
            "autores" => array:3 [
              0 => array:2 [
                "nombre" => "F&#46;"
                "apellidos" => "Alamon-Reig"
              ]
              1 => array:2 [
                "nombre" => "M&#46;C&#46;"
                "apellidos" => "Bois"
              ]
              2 => array:2 [
                "nombre" => "D&#46;"
                "apellidos" => "Morgado-Carrasco"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "en"
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731022000199?idApp=UINPBA000044"
      "url" => "/00017310/0000011300000001/v2_202202160543/S0001731022000199/v2_202202160543/en/main.assets"
    ]
  ]
  "es" => array:13 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">FORO DE RESIDENTES</span>"
    "titulo" => "FR - Nuevos f&#225;rmacos para el manejo del acn&#233;"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "86"
        "paginaFinal" => "88"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "F&#46; Alamon-Reig, M&#46;C&#46; Bois, D&#46; Morgado-Carrasco"
        "autores" => array:3 [
          0 => array:2 [
            "nombre" => "F&#46;"
            "apellidos" => "Alamon-Reig"
          ]
          1 => array:2 [
            "nombre" => "M&#46;C&#46;"
            "apellidos" => "Bois"
          ]
          2 => array:4 [
            "nombre" => "D&#46;"
            "apellidos" => "Morgado-Carrasco"
            "email" => array:1 [
              0 => "morgadodaniel8@gmail.com"
            ]
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:2 [
            "entidad" => "Servicio de Dermatolog&#237;a&#44; Hospital Cl&#237;nic de Barcelona&#44; Universitat de Barcelona&#44; Barcelona&#44; Espa&#241;a"
            "identificador" => "aff0005"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Autor para correspondencia&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "en" => array:1 [
        "titulo" => "RF - New Drugs for Managing Acne"
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">El acn&#233; vulgar es una afecci&#243;n cut&#225;nea muy prevalente que puede impactar considerablemente sobre la calidad de vida&#46; Los retinoides t&#243;picos&#44; el per&#243;xido de benzoilo&#44; diversos antibi&#243;ticos y la isotretino&#237;na son los pilares terap&#233;uticos desde hace d&#233;cadas&#46; La aprobaci&#243;n reciente de un nuevo antibi&#243;tico por la <span class="elsevierStyleItalic">U&#46; S&#46; Food and Drug Administration</span> para las formas moderadas-severas del acn&#233;&#44; junto con otros nuevos f&#225;rmacos en desarrollo&#44; podr&#237;an incrementar el arsenal terap&#233;utico&#46;</p><p id="par0010" class="elsevierStylePara elsevierViewall">La sareciclina es un derivado de las tetraciclinas con un espectro antibi&#243;tico reducido &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">tabla 1</a>&#41; y una probabilidad menor de generar una resistencia antibi&#243;tica&#46; Los ensayos cl&#237;nicos SC1401 &#40;n<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>968&#41; y SC1402 &#40;n<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>1&#46;034&#41; incluyeron pacientes con un acn&#233; moderado-severo&#44; aleatoriz&#225;ndolos a recibir sareciclina o placebo&#46; El principal par&#225;metro evaluado fue el <span class="elsevierStyleItalic">Investigator&#39;s Global Assessment</span> &#40;IGA&#41; <span class="elsevierStyleItalic">success&#44;</span> equivalente a la reducci&#243;n de<span class="elsevierStyleHsp" style=""></span>&#8805;<span class="elsevierStyleHsp" style=""></span>2 puntos en el IGA y alcanzar una puntuaci&#243;n de 0 &#40;sin lesiones&#41; o 1 &#40;con apenas lesiones&#41; a las 12 semanas&#46; Dicho criterio fue alcanzado por un 21&#44;9 y un 22&#44;6&#37;&#44; respectivamente&#44; en el grupo tratado con sareciclina&#44; frente a un 10&#44;5 y un 15&#44;3&#37; en el grupo placebo &#40;p<span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#44;0001 y p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;0038&#41;&#46; Los efectos adversos m&#225;s frecuentes fueron n&#225;useas&#44; nasofaringitis y cefalea<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">1</span></a>&#46; El ensayo cl&#237;nico PR-10411 &#40;n<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>285&#41; compar&#243; la efectividad de 3 dosis diferentes de sareciclina &#40;0&#44;75&#44; 1&#44;5 y 3<span class="elsevierStyleHsp" style=""></span>mg&#47;kg&#41; frente a placebo&#44; evaluando la reducci&#243;n de las lesiones en la semana 12&#46; Se alcanzaron unos resultados significativos en los grupos de 1&#44;5 y 3<span class="elsevierStyleHsp" style=""></span>mg&#47;kg&#44; con una reducci&#243;n de las lesiones<span class="elsevierStyleHsp" style=""></span>&#62;<span class="elsevierStyleHsp" style=""></span>50&#37;&#44; sin observar una diferencia entre los 2 grupos de mayor dosificaci&#243;n<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">2</span></a>&#46; Estos estudios motivaron la aprobaci&#243;n de sareciclina&#44; el primer f&#225;rmaco sist&#233;mico aprobado para el acn&#233; por la <span class="elsevierStyleItalic">U&#46; S&#46; Food and Drug Administration</span> en m&#225;s de 40 a&#241;os&#46; Otra alternativa antibi&#243;tica novedosa es la minociclina 4&#37; t&#243;pica&#44; tetraciclina con una actividad bactericida contra el <span class="elsevierStyleItalic">Cutinebacterium acnes</span> y una absorci&#243;n sist&#233;mica pr&#225;cticamente nula&#46; El ensayo aleatorizado FX2017-22 &#40;n<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>1&#46;488&#41; la compar&#243; frente a placebo&#44; con una reducci&#243;n significativa de las lesiones inflamatorias en la semana 12 &#40;p<span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#44;0001&#41; y una mejor&#237;a del IGA &#40;p<span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#44;0001&#41; en el grupo intervenci&#243;n<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">3</span></a>&#46;</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0015" class="elsevierStylePara elsevierViewall">Recientemente&#44; se ha alcanzado una mayor comprensi&#243;n de la sebog&#233;nesis&#44; la cual ser&#237;a modulada por andr&#243;genos&#44; el sistema endocannabinoide y m&#250;ltiples mediadores proinflamatorios como la histamina y los leucotrienos&#44; lo que ha abierto nuevas l&#237;neas de investigaci&#243;n terap&#233;utica&#46; Entre los tratamientos t&#243;picos&#44; la clascoterona&#44; antagonista competitivo del receptor de andr&#243;genos&#44; demostr&#243; una superioridad frente al placebo en 2 ensayos fase 3&#44; evaluados mediante IGA<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">4</span></a>&#46; La clascoterona ser&#237;a el primer antiandr&#243;geno sin una repercusi&#243;n hormonal sist&#233;mica y podr&#237;a ser utilizado en los hombres&#46; El cannabidiol es un cannabinoide no psicotr&#243;pico con unas propiedades antiinflamatorias&#44; sebost&#225;ticas y antimicrobianas que ha demostrado una tolerancia buena en estudios fase 1b&#46; Actualmente&#44; se est&#225; finalizando un ensayo fase 2 &#40;f&#225;rmaco BTX1503&#41;&#44; que eval&#250;a la efectividad del cannabidiol t&#243;pico en el acn&#233;&#46; Entre los tratamientos sist&#233;micos&#44; un ensayo cl&#237;nico aleatorizado &#40;n<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>100&#41; mostr&#243; que la combinaci&#243;n de levocetirizina &#40;antihistam&#237;nico no sedante&#41; e isotretino&#237;na era superior y presentaba menos efectos adversos que el tratamiento exclusivo con isotretino&#237;na<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">5</span></a>&#46; Se han obtenido unos resultados similares utilizando desloratadina<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">6</span></a>&#46; Los antihistam&#237;nicos modular&#237;an la sebog&#233;nesis y disminuir&#237;an los efectos adversos de los retinoides&#46;</p><p id="par0020" class="elsevierStylePara elsevierViewall">El desarrollo de estos nuevos f&#225;rmacos podr&#237;a modificar el tratamiento del acn&#233;&#46; Es fundamental conocerlos y conseguir una mayor eficacia y seguridad en el tratamiento de esta afecci&#243;n&#46;</p></span>"
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "PalabrasClave" => array:1 [
      "es" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec1479691"
          "palabras" => array:6 [
            0 => "Acn&#233;"
            1 => "Tratamiento"
            2 => "Sareciclina"
            3 => "Clascoterona"
            4 => "Minociclina"
            5 => "Cannabidiol"
          ]
        ]
      ]
    ]
    "multimedia" => array:1 [
      0 => array:8 [
        "identificador" => "tbl0005"
        "etiqueta" => "Tabla 1"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at1"
            "detalle" => "Tabla "
            "rol" => "short"
          ]
        ]
        "tabla" => array:2 [
          "leyenda" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleItalic">C&#46; acnes&#58; Cutinebacterium acnes&#59;</span> EMA&#58; <span class="elsevierStyleItalic">European Medicines Agency&#59;</span> FDA&#58; <span class="elsevierStyleItalic">U&#46; S&#46; Food and Drug Administration&#59;</span> IGF-1&#58; factores de crecimiento similares a la insulina tipo 1&#59; NF-&#954;B&#58; factor nuclear potenciador de las cadenas ligeras kappa de las c&#233;lulas B activadas&#59; RAR&#58; Receptor del &#225;cido retinoico&#46;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">F&#225;rmaco&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Diana terap&#233;utica&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Mecanismo de acci&#243;n&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">V&#237;a de administraci&#243;n&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Efectos adversos frecuentes&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Aprobaci&#243;n por la FDA&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Aprobaci&#243;n por la EMA&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">SareciclinaAntibi&#243;tico derivado de las tetraciclinas&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">C&#46; acnes</span> &#40;anaerobio grampositivo&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Inhibe la s&#237;ntesis proteica bacteriana uni&#233;ndose a la subunidad 30S ribosomal&#46; Tambi&#233;n presenta un efecto antiinflamatorio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1&#44;5<span class="elsevierStyleHsp" style=""></span>mg&#47;kg una vez al d&#237;a por v&#237;a oral&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">N&#225;useas&#44; nasofaringitis y cefalea&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">S&#237;&#44; en octubre de 2018&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">No&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">ClascoteronaAntiandr&#243;geno&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Receptor de andr&#243;genos cut&#225;neo&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Bloquea la acci&#243;n androg&#233;nica&#44; al competir con la dihidrotestosterona por su uni&#243;n al receptor&#44; y de esa forma inhibir la transcripci&#243;n de genes sensibles a andr&#243;genos&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Crema al 1&#37; v&#237;a t&#243;picaDos veces al d&#237;a&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Eritema y prurito en sitio de aplicaci&#243;n&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">No&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">No&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">TazarotenoRetinoide t&#243;pico de tercera generaci&#243;n&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Receptor de retinoides cut&#225;neo &#40;RAR&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Regula la expresi&#243;n g&#233;nica&#44; modulando la proliferaci&#243;n&#44; hiperplasia y diferenciaci&#243;n celular&#44; evitando as&#237; la formaci&#243;n del tap&#243;n hiperquerat&#243;sico en el fol&#237;culo piloseb&#225;ceo&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Espuma al 0&#44;1&#37; v&#237;a t&#243;pica una vez al d&#237;a&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Irritaci&#243;n y sequedad cut&#225;nea en el sitio de aplicaci&#243;n&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">S&#237;&#44; en 2012Relanzado al mercado recientemente&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">No&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Minociclina t&#243;picaAntibi&#243;tico &#40;FMX101 4&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">C&#46; acnes</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">Antibi&#243;tico de amplio espectro&#44; bactericida&#44; inhibe la s&#237;ntesis proteica del C&#46; acnes</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Espuma al 4&#37;&#44; v&#237;a t&#243;picaUna vez al d&#237;a&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Irritaci&#243;n en sitio de aplicaci&#243;n&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">No&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">No&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">CannabidiolCannabinoide no psicotr&#243;pico &#40;BTX 1503&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Sistema endocannabinoide cut&#225;neo &#40;receptores CB1&#47;CB2&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Activa los receptores CB1 y CB2 epid&#233;rmicos&#44; pudiendo aumentar la metilaci&#243;n del ADN de los queratinocitos&#44; v&#237;a MAP cinasa p38&#44; e inhibir su proliferaci&#243;n&#46; Tambi&#233;n regula la producci&#243;n de sebo mediante la v&#237;a TRPV4 en la gl&#225;ndula seb&#225;cea&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Formulaci&#243;n l&#237;quida&#44; v&#237;a t&#243;picaUna a 2 veces al d&#237;a&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Eritema local&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">No&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">No&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Olumacostat glasaretilAntiandr&#243;geno &#40;DRM01&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Antiandr&#243;geno&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Evita la s&#237;ntesis de &#225;cidos grasos saturados&#44; inhibiendo a la acetil coenzima A carboxilasa&#59; e indirectamente&#44; previene el crecimiento del <span class="elsevierStyleItalic">C&#46; acnes</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Gel al 7&#44;5&#37;&#44; v&#237;a t&#243;picaDos veces al d&#237;a&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Irritaci&#243;n y sequedad cut&#225;nea en el sitio de aplicaci&#243;n&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">No&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">No&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Epigallocatechin-3-gallateCatequina&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Seborregulador y antiinflamatorio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Inhibe la proliferaci&#243;n de sebocitos y la s&#237;ntesis de l&#237;pidos v&#237;a IGF-1&#44; disminuye la inflamaci&#243;n al inhibir al NF-&#954;B y al activador de la prote&#237;na 1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Soluci&#243;n al 1&#37;&#44; v&#237;a t&#243;picaDos veces al d&#237;a&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Eritema local&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">No&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">No&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab2835227.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Caracter&#237;sticas de los nuevos f&#225;rmacos aprobados o en desarrollo para el tratamiento del acn&#233;</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "Bibliograf&#237;a"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0015"
          "bibliografiaReferencia" => array:6 [
            0 => array:3 [
              "identificador" => "bib0035"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Once-daily oral sarecycline 1&#46;5<span class="elsevierStyleHsp" style=""></span>mg&#47;kg&#47;day is effective for moderate to severe acne vulgaris&#58; Results from two identically designed&#44; phase 3&#44; randomized double-blind clinical trials"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "A&#46; Moore"
                            1 => "L&#46;J&#46; Green"
                            2 => "S&#46; Bruce"
                            3 => "N&#46; Sadick"
                            4 => "E&#46; Tschen"
                            5 => "P&#46; Werschler"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Drugs Dermatol&#46;"
                        "fecha" => "2018"
                        "volumen" => "17"
                        "paginaInicial" => "987"
                        "paginaFinal" => "996"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30235387"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0040"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Efficacy and safety of sarecycline&#44; a novel&#44; once-daily narrow spectrum antibiotic for the treatment of moderate to severe facial acne vulgaris&#58; Results of a phase 2&#44; dose-ranging study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "J&#46;J&#46; Leyden"
                            1 => "V&#46; Sniukiene"
                            2 => "D&#46;R&#46; Berk"
                            3 => "A&#46; Kaoukhov"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Drugs Dermatol&#46;"
                        "fecha" => "2018"
                        "volumen" => "17"
                        "paginaInicial" => "333"
                        "paginaFinal" => "338"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29537451"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0045"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Efficacy and safety of a novel topical minocycline foam for the treatment of moderate to severe acne vulgaris&#58; A phase 3 study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "T&#46;J&#46; Raoof"
                            1 => "D&#46; Hooper"
                            2 => "A&#46; Moore"
                            3 => "M&#46; Zaiac"
                            4 => "T&#46; Sullivan"
                            5 => "L&#46; Kircik"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jaad.2019.05.078"
                      "Revista" => array:5 [
                        "tituloSerie" => "J Am Acad Dermatol&#46;"
                        "fecha" => "2020"
                        "volumen" => "82"
                        "paginaInicial" => "832"
                        "paginaFinal" => "837"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0050"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Pharmacokinetic profile&#44; safety&#44; and tolerability of clascoterone &#40;cortexolone 17-alpha propionate&#44; CB-03-01&#41; topical cream&#44; 1&#37; in subjects with acne vulgaris&#58; An open-label phase 2a study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "A&#46; Mazzetti"
                            1 => "L&#46; Moro"
                            2 => "M&#46; Gerloni"
                            3 => "M&#46; Cartwright"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "J Drugs Dermatol"
                        "fecha" => "2019"
                        "volumen" => "18"
                        "paginaInicial" => "563"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31251549"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0055"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Efficacy of isotretinoin and antihistamine versus isotretinoin alone in the treatment of moderate to severe acne&#58; A randomised control trial"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "D&#46; Pandey"
                            1 => "S&#46; Agrawal"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Kathmandu Univ Med J &#40;KUMJ&#41;&#46;"
                        "fecha" => "2019"
                        "volumen" => "17"
                        "paginaInicial" => "14"
                        "paginaFinal" => "19"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0060"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Efficacy of oral isotretinoin in combination with desloratadine in the treatment of common vulgaris acne in Vietnamese patients"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "T&#46;N&#46; Van"
                            1 => "L&#46;D&#46; Thi"
                            2 => "H&#46;N&#46; Trong"
                            3 => "T&#46;C&#46; Van"
                            4 => "T&#46;T&#46; Minh"
                            5 => "P&#46;P&#46;T&#46; Minh"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.3889/oamjms.2019.054"
                      "Revista" => array:6 [
                        "tituloSerie" => "Open Access Maced J Med Sci&#46;"
                        "fecha" => "2019"
                        "volumen" => "7"
                        "paginaInicial" => "217"
                        "paginaFinal" => "220"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30745963"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "es"
  "url" => "/00017310/0000011300000001/v2_202202160543/S0001731021002854/v2_202202160543/es/main.assets"
  "Apartado" => array:4 [
    "identificador" => "92872"
    "tipo" => "SECCION"
    "es" => array:2 [
      "titulo" => "Foro de Residentes &#47; Resident&#39;s Forum"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "es"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/00017310/0000011300000001/v2_202202160543/S0001731021002854/v2_202202160543/es/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731021002854?idApp=UINPBA000044"
]
Share
Journal Information

Statistics

Follow this link to access the full text of the article

FORO DE RESIDENTES
FR - Nuevos fármacos para el manejo del acné
RF - New Drugs for Managing Acne
F. Alamon-Reig, M.C. Bois, D. Morgado-Carrasco
Corresponding author
morgadodaniel8@gmail.com

Autor para correspondencia.
Servicio de Dermatología, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, España
Read
18213
Times
was read the article
4115
Total PDF
14098
Total HTML
Share statistics
 array:25 [
  "pii" => "S0001731021002854"
  "issn" => "00017310"
  "doi" => "10.1016/j.ad.2020.01.020"
  "estado" => "S300"
  "fechaPublicacion" => "2022-01-01"
  "aid" => "2718"
  "copyright" => "AEDV"
  "copyrightAnyo" => "2021"
  "documento" => "article"
  "crossmark" => 1
  "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
  "subdocumento" => "sco"
  "cita" => "Actas Dermosifiliogr. 2022;113:86-8"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:1 [
    "total" => 0
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S0001731022000199"
    "issn" => "00017310"
    "doi" => "10.1016/j.ad.2020.01.021"
    "estado" => "S300"
    "fechaPublicacion" => "2022-01-01"
    "aid" => "2881"
    "copyright" => "AEDV"
    "documento" => "article"
    "crossmark" => 1
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "sco"
    "cita" => "Actas Dermosifiliogr. 2022;113:T86-T88"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:1 [
      "total" => 0
    ]
    "en" => array:10 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Resident&#8217;s Forum</span>"
      "titulo" => " RF - New Drugs for Managing Acne"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "T86"
          "paginaFinal" => "T88"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "FR - Nuevos f&#225;rmacos para el manejo del acn&#233;"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "F&#46; Alamon-Reig, M&#46;C&#46; Bois, D&#46; Morgado-Carrasco"
          "autores" => array:3 [
            0 => array:2 [
              "nombre" => "F&#46;"
              "apellidos" => "Alamon-Reig"
            ]
            1 => array:2 [
              "nombre" => "M&#46;C&#46;"
              "apellidos" => "Bois"
            ]
            2 => array:2 [
              "nombre" => "D&#46;"
              "apellidos" => "Morgado-Carrasco"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731022000199?idApp=UINPBA000044"
    "url" => "/00017310/0000011300000001/v2_202202160543/S0001731022000199/v2_202202160543/en/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S0001731021002799"
    "issn" => "00017310"
    "doi" => "10.1016/j.ad.2020.05.013"
    "estado" => "S300"
    "fechaPublicacion" => "2022-01-01"
    "aid" => "2712"
    "documento" => "article"
    "crossmark" => 1
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "sco"
    "cita" => "Actas Dermosifiliogr. 2022;113:T85"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:1 [
      "total" => 0
    ]
    "es" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">IM&#193;GENES EN DERMATOLOG&#205;A</span>"
      "titulo" => " Aplasia cutis cong&#233;nita asociada a trisom&#237;a 13"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "paginas" => array:1 [
        0 => array:1 [
          "paginaInicial" => "T85"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "Aplasia Cutis Congenita Associated with Trisomy 13"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:6 [
          "identificador" => "fig0005"
          "etiqueta" => "Figura 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 681
              "Ancho" => 905
              "Tamanyo" => 127494
            ]
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "J&#46; Mart&#237;nez-Coronado, Y&#46; Chong-Cazares"
          "autores" => array:2 [
            0 => array:2 [
              "nombre" => "J&#46;"
              "apellidos" => "Mart&#237;nez-Coronado"
            ]
            1 => array:2 [
              "nombre" => "Y&#46;"
              "apellidos" => "Chong-Cazares"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S1578219021003176"
        "doi" => "10.1016/j.adengl.2021.11.013"
        "estado" => "S200"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219021003176?idApp=UINPBA000044"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731021002799?idApp=UINPBA000044"
    "url" => "/00017310/0000011300000001/v2_202202160543/S0001731021002799/v2_202202160543/es/main.assets"
  ]
  "asociados" => array:1 [
    0 => array:19 [
      "pii" => "S0001731022000199"
      "issn" => "00017310"
      "doi" => "10.1016/j.ad.2020.01.021"
      "estado" => "S300"
      "fechaPublicacion" => "2022-01-01"
      "aid" => "2881"
      "copyright" => "AEDV"
      "documento" => "article"
      "crossmark" => 1
      "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
      "subdocumento" => "sco"
      "cita" => "Actas Dermosifiliogr. 2022;113:T86-T88"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:1 [
        "total" => 0
      ]
      "en" => array:10 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Resident&#8217;s Forum</span>"
        "titulo" => " RF - New Drugs for Managing Acne"
        "tienePdf" => "en"
        "tieneTextoCompleto" => "en"
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "T86"
            "paginaFinal" => "T88"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "es" => array:1 [
            "titulo" => "FR - Nuevos f&#225;rmacos para el manejo del acn&#233;"
          ]
        ]
        "contieneTextoCompleto" => array:1 [
          "en" => true
        ]
        "contienePdf" => array:1 [
          "en" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "F&#46; Alamon-Reig, M&#46;C&#46; Bois, D&#46; Morgado-Carrasco"
            "autores" => array:3 [
              0 => array:2 [
                "nombre" => "F&#46;"
                "apellidos" => "Alamon-Reig"
              ]
              1 => array:2 [
                "nombre" => "M&#46;C&#46;"
                "apellidos" => "Bois"
              ]
              2 => array:2 [
                "nombre" => "D&#46;"
                "apellidos" => "Morgado-Carrasco"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "en"
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731022000199?idApp=UINPBA000044"
      "url" => "/00017310/0000011300000001/v2_202202160543/S0001731022000199/v2_202202160543/en/main.assets"
    ]
  ]
  "es" => array:13 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">FORO DE RESIDENTES</span>"
    "titulo" => "FR - Nuevos f&#225;rmacos para el manejo del acn&#233;"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "86"
        "paginaFinal" => "88"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "F&#46; Alamon-Reig, M&#46;C&#46; Bois, D&#46; Morgado-Carrasco"
        "autores" => array:3 [
          0 => array:2 [
            "nombre" => "F&#46;"
            "apellidos" => "Alamon-Reig"
          ]
          1 => array:2 [
            "nombre" => "M&#46;C&#46;"
            "apellidos" => "Bois"
          ]
          2 => array:4 [
            "nombre" => "D&#46;"
            "apellidos" => "Morgado-Carrasco"
            "email" => array:1 [
              0 => "morgadodaniel8@gmail.com"
            ]
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:2 [
            "entidad" => "Servicio de Dermatolog&#237;a&#44; Hospital Cl&#237;nic de Barcelona&#44; Universitat de Barcelona&#44; Barcelona&#44; Espa&#241;a"
            "identificador" => "aff0005"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Autor para correspondencia&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "en" => array:1 [
        "titulo" => "RF - New Drugs for Managing Acne"
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">El acn&#233; vulgar es una afecci&#243;n cut&#225;nea muy prevalente que puede impactar considerablemente sobre la calidad de vida&#46; Los retinoides t&#243;picos&#44; el per&#243;xido de benzoilo&#44; diversos antibi&#243;ticos y la isotretino&#237;na son los pilares terap&#233;uticos desde hace d&#233;cadas&#46; La aprobaci&#243;n reciente de un nuevo antibi&#243;tico por la <span class="elsevierStyleItalic">U&#46; S&#46; Food and Drug Administration</span> para las formas moderadas-severas del acn&#233;&#44; junto con otros nuevos f&#225;rmacos en desarrollo&#44; podr&#237;an incrementar el arsenal terap&#233;utico&#46;</p><p id="par0010" class="elsevierStylePara elsevierViewall">La sareciclina es un derivado de las tetraciclinas con un espectro antibi&#243;tico reducido &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">tabla 1</a>&#41; y una probabilidad menor de generar una resistencia antibi&#243;tica&#46; Los ensayos cl&#237;nicos SC1401 &#40;n<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>968&#41; y SC1402 &#40;n<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>1&#46;034&#41; incluyeron pacientes con un acn&#233; moderado-severo&#44; aleatoriz&#225;ndolos a recibir sareciclina o placebo&#46; El principal par&#225;metro evaluado fue el <span class="elsevierStyleItalic">Investigator&#39;s Global Assessment</span> &#40;IGA&#41; <span class="elsevierStyleItalic">success&#44;</span> equivalente a la reducci&#243;n de<span class="elsevierStyleHsp" style=""></span>&#8805;<span class="elsevierStyleHsp" style=""></span>2 puntos en el IGA y alcanzar una puntuaci&#243;n de 0 &#40;sin lesiones&#41; o 1 &#40;con apenas lesiones&#41; a las 12 semanas&#46; Dicho criterio fue alcanzado por un 21&#44;9 y un 22&#44;6&#37;&#44; respectivamente&#44; en el grupo tratado con sareciclina&#44; frente a un 10&#44;5 y un 15&#44;3&#37; en el grupo placebo &#40;p<span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#44;0001 y p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;0038&#41;&#46; Los efectos adversos m&#225;s frecuentes fueron n&#225;useas&#44; nasofaringitis y cefalea<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">1</span></a>&#46; El ensayo cl&#237;nico PR-10411 &#40;n<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>285&#41; compar&#243; la efectividad de 3 dosis diferentes de sareciclina &#40;0&#44;75&#44; 1&#44;5 y 3<span class="elsevierStyleHsp" style=""></span>mg&#47;kg&#41; frente a placebo&#44; evaluando la reducci&#243;n de las lesiones en la semana 12&#46; Se alcanzaron unos resultados significativos en los grupos de 1&#44;5 y 3<span class="elsevierStyleHsp" style=""></span>mg&#47;kg&#44; con una reducci&#243;n de las lesiones<span class="elsevierStyleHsp" style=""></span>&#62;<span class="elsevierStyleHsp" style=""></span>50&#37;&#44; sin observar una diferencia entre los 2 grupos de mayor dosificaci&#243;n<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">2</span></a>&#46; Estos estudios motivaron la aprobaci&#243;n de sareciclina&#44; el primer f&#225;rmaco sist&#233;mico aprobado para el acn&#233; por la <span class="elsevierStyleItalic">U&#46; S&#46; Food and Drug Administration</span> en m&#225;s de 40 a&#241;os&#46; Otra alternativa antibi&#243;tica novedosa es la minociclina 4&#37; t&#243;pica&#44; tetraciclina con una actividad bactericida contra el <span class="elsevierStyleItalic">Cutinebacterium acnes</span> y una absorci&#243;n sist&#233;mica pr&#225;cticamente nula&#46; El ensayo aleatorizado FX2017-22 &#40;n<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>1&#46;488&#41; la compar&#243; frente a placebo&#44; con una reducci&#243;n significativa de las lesiones inflamatorias en la semana 12 &#40;p<span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#44;0001&#41; y una mejor&#237;a del IGA &#40;p<span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#44;0001&#41; en el grupo intervenci&#243;n<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">3</span></a>&#46;</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0015" class="elsevierStylePara elsevierViewall">Recientemente&#44; se ha alcanzado una mayor comprensi&#243;n de la sebog&#233;nesis&#44; la cual ser&#237;a modulada por andr&#243;genos&#44; el sistema endocannabinoide y m&#250;ltiples mediadores proinflamatorios como la histamina y los leucotrienos&#44; lo que ha abierto nuevas l&#237;neas de investigaci&#243;n terap&#233;utica&#46; Entre los tratamientos t&#243;picos&#44; la clascoterona&#44; antagonista competitivo del receptor de andr&#243;genos&#44; demostr&#243; una superioridad frente al placebo en 2 ensayos fase 3&#44; evaluados mediante IGA<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">4</span></a>&#46; La clascoterona ser&#237;a el primer antiandr&#243;geno sin una repercusi&#243;n hormonal sist&#233;mica y podr&#237;a ser utilizado en los hombres&#46; El cannabidiol es un cannabinoide no psicotr&#243;pico con unas propiedades antiinflamatorias&#44; sebost&#225;ticas y antimicrobianas que ha demostrado una tolerancia buena en estudios fase 1b&#46; Actualmente&#44; se est&#225; finalizando un ensayo fase 2 &#40;f&#225;rmaco BTX1503&#41;&#44; que eval&#250;a la efectividad del cannabidiol t&#243;pico en el acn&#233;&#46; Entre los tratamientos sist&#233;micos&#44; un ensayo cl&#237;nico aleatorizado &#40;n<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>100&#41; mostr&#243; que la combinaci&#243;n de levocetirizina &#40;antihistam&#237;nico no sedante&#41; e isotretino&#237;na era superior y presentaba menos efectos adversos que el tratamiento exclusivo con isotretino&#237;na<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">5</span></a>&#46; Se han obtenido unos resultados similares utilizando desloratadina<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">6</span></a>&#46; Los antihistam&#237;nicos modular&#237;an la sebog&#233;nesis y disminuir&#237;an los efectos adversos de los retinoides&#46;</p><p id="par0020" class="elsevierStylePara elsevierViewall">El desarrollo de estos nuevos f&#225;rmacos podr&#237;a modificar el tratamiento del acn&#233;&#46; Es fundamental conocerlos y conseguir una mayor eficacia y seguridad en el tratamiento de esta afecci&#243;n&#46;</p></span>"
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "PalabrasClave" => array:1 [
      "es" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec1479691"
          "palabras" => array:6 [
            0 => "Acn&#233;"
            1 => "Tratamiento"
            2 => "Sareciclina"
            3 => "Clascoterona"
            4 => "Minociclina"
            5 => "Cannabidiol"
          ]
        ]
      ]
    ]
    "multimedia" => array:1 [
      0 => array:8 [
        "identificador" => "tbl0005"
        "etiqueta" => "Tabla 1"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at1"
            "detalle" => "Tabla "
            "rol" => "short"
          ]
        ]
        "tabla" => array:2 [
          "leyenda" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleItalic">C&#46; acnes&#58; Cutinebacterium acnes&#59;</span> EMA&#58; <span class="elsevierStyleItalic">European Medicines Agency&#59;</span> FDA&#58; <span class="elsevierStyleItalic">U&#46; S&#46; Food and Drug Administration&#59;</span> IGF-1&#58; factores de crecimiento similares a la insulina tipo 1&#59; NF-&#954;B&#58; factor nuclear potenciador de las cadenas ligeras kappa de las c&#233;lulas B activadas&#59; RAR&#58; Receptor del &#225;cido retinoico&#46;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">F&#225;rmaco&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Diana terap&#233;utica&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Mecanismo de acci&#243;n&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">V&#237;a de administraci&#243;n&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Efectos adversos frecuentes&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Aprobaci&#243;n por la FDA&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Aprobaci&#243;n por la EMA&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">SareciclinaAntibi&#243;tico derivado de las tetraciclinas&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">C&#46; acnes</span> &#40;anaerobio grampositivo&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Inhibe la s&#237;ntesis proteica bacteriana uni&#233;ndose a la subunidad 30S ribosomal&#46; Tambi&#233;n presenta un efecto antiinflamatorio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1&#44;5<span class="elsevierStyleHsp" style=""></span>mg&#47;kg una vez al d&#237;a por v&#237;a oral&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">N&#225;useas&#44; nasofaringitis y cefalea&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">S&#237;&#44; en octubre de 2018&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">No&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">ClascoteronaAntiandr&#243;geno&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Receptor de andr&#243;genos cut&#225;neo&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Bloquea la acci&#243;n androg&#233;nica&#44; al competir con la dihidrotestosterona por su uni&#243;n al receptor&#44; y de esa forma inhibir la transcripci&#243;n de genes sensibles a andr&#243;genos&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Crema al 1&#37; v&#237;a t&#243;picaDos veces al d&#237;a&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Eritema y prurito en sitio de aplicaci&#243;n&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">No&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">No&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">TazarotenoRetinoide t&#243;pico de tercera generaci&#243;n&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Receptor de retinoides cut&#225;neo &#40;RAR&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Regula la expresi&#243;n g&#233;nica&#44; modulando la proliferaci&#243;n&#44; hiperplasia y diferenciaci&#243;n celular&#44; evitando as&#237; la formaci&#243;n del tap&#243;n hiperquerat&#243;sico en el fol&#237;culo piloseb&#225;ceo&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Espuma al 0&#44;1&#37; v&#237;a t&#243;pica una vez al d&#237;a&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Irritaci&#243;n y sequedad cut&#225;nea en el sitio de aplicaci&#243;n&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">S&#237;&#44; en 2012Relanzado al mercado recientemente&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">No&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Minociclina t&#243;picaAntibi&#243;tico &#40;FMX101 4&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">C&#46; acnes</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">Antibi&#243;tico de amplio espectro&#44; bactericida&#44; inhibe la s&#237;ntesis proteica del C&#46; acnes</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Espuma al 4&#37;&#44; v&#237;a t&#243;picaUna vez al d&#237;a&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Irritaci&#243;n en sitio de aplicaci&#243;n&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">No&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">No&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">CannabidiolCannabinoide no psicotr&#243;pico &#40;BTX 1503&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Sistema endocannabinoide cut&#225;neo &#40;receptores CB1&#47;CB2&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Activa los receptores CB1 y CB2 epid&#233;rmicos&#44; pudiendo aumentar la metilaci&#243;n del ADN de los queratinocitos&#44; v&#237;a MAP cinasa p38&#44; e inhibir su proliferaci&#243;n&#46; Tambi&#233;n regula la producci&#243;n de sebo mediante la v&#237;a TRPV4 en la gl&#225;ndula seb&#225;cea&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Formulaci&#243;n l&#237;quida&#44; v&#237;a t&#243;picaUna a 2 veces al d&#237;a&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Eritema local&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">No&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">No&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Olumacostat glasaretilAntiandr&#243;geno &#40;DRM01&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Antiandr&#243;geno&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Evita la s&#237;ntesis de &#225;cidos grasos saturados&#44; inhibiendo a la acetil coenzima A carboxilasa&#59; e indirectamente&#44; previene el crecimiento del <span class="elsevierStyleItalic">C&#46; acnes</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Gel al 7&#44;5&#37;&#44; v&#237;a t&#243;picaDos veces al d&#237;a&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Irritaci&#243;n y sequedad cut&#225;nea en el sitio de aplicaci&#243;n&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">No&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">No&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Epigallocatechin-3-gallateCatequina&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Seborregulador y antiinflamatorio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Inhibe la proliferaci&#243;n de sebocitos y la s&#237;ntesis de l&#237;pidos v&#237;a IGF-1&#44; disminuye la inflamaci&#243;n al inhibir al NF-&#954;B y al activador de la prote&#237;na 1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Soluci&#243;n al 1&#37;&#44; v&#237;a t&#243;picaDos veces al d&#237;a&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Eritema local&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">No&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">No&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab2835227.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Caracter&#237;sticas de los nuevos f&#225;rmacos aprobados o en desarrollo para el tratamiento del acn&#233;</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "Bibliograf&#237;a"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0015"
          "bibliografiaReferencia" => array:6 [
            0 => array:3 [
              "identificador" => "bib0035"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Once-daily oral sarecycline 1&#46;5<span class="elsevierStyleHsp" style=""></span>mg&#47;kg&#47;day is effective for moderate to severe acne vulgaris&#58; Results from two identically designed&#44; phase 3&#44; randomized double-blind clinical trials"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "A&#46; Moore"
                            1 => "L&#46;J&#46; Green"
                            2 => "S&#46; Bruce"
                            3 => "N&#46; Sadick"
                            4 => "E&#46; Tschen"
                            5 => "P&#46; Werschler"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Drugs Dermatol&#46;"
                        "fecha" => "2018"
                        "volumen" => "17"
                        "paginaInicial" => "987"
                        "paginaFinal" => "996"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30235387"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0040"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Efficacy and safety of sarecycline&#44; a novel&#44; once-daily narrow spectrum antibiotic for the treatment of moderate to severe facial acne vulgaris&#58; Results of a phase 2&#44; dose-ranging study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "J&#46;J&#46; Leyden"
                            1 => "V&#46; Sniukiene"
                            2 => "D&#46;R&#46; Berk"
                            3 => "A&#46; Kaoukhov"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Drugs Dermatol&#46;"
                        "fecha" => "2018"
                        "volumen" => "17"
                        "paginaInicial" => "333"
                        "paginaFinal" => "338"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29537451"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0045"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Efficacy and safety of a novel topical minocycline foam for the treatment of moderate to severe acne vulgaris&#58; A phase 3 study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "T&#46;J&#46; Raoof"
                            1 => "D&#46; Hooper"
                            2 => "A&#46; Moore"
                            3 => "M&#46; Zaiac"
                            4 => "T&#46; Sullivan"
                            5 => "L&#46; Kircik"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jaad.2019.05.078"
                      "Revista" => array:5 [
                        "tituloSerie" => "J Am Acad Dermatol&#46;"
                        "fecha" => "2020"
                        "volumen" => "82"
                        "paginaInicial" => "832"
                        "paginaFinal" => "837"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0050"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Pharmacokinetic profile&#44; safety&#44; and tolerability of clascoterone &#40;cortexolone 17-alpha propionate&#44; CB-03-01&#41; topical cream&#44; 1&#37; in subjects with acne vulgaris&#58; An open-label phase 2a study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "A&#46; Mazzetti"
                            1 => "L&#46; Moro"
                            2 => "M&#46; Gerloni"
                            3 => "M&#46; Cartwright"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "J Drugs Dermatol"
                        "fecha" => "2019"
                        "volumen" => "18"
                        "paginaInicial" => "563"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31251549"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0055"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Efficacy of isotretinoin and antihistamine versus isotretinoin alone in the treatment of moderate to severe acne&#58; A randomised control trial"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "D&#46; Pandey"
                            1 => "S&#46; Agrawal"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Kathmandu Univ Med J &#40;KUMJ&#41;&#46;"
                        "fecha" => "2019"
                        "volumen" => "17"
                        "paginaInicial" => "14"
                        "paginaFinal" => "19"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0060"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Efficacy of oral isotretinoin in combination with desloratadine in the treatment of common vulgaris acne in Vietnamese patients"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "T&#46;N&#46; Van"
                            1 => "L&#46;D&#46; Thi"
                            2 => "H&#46;N&#46; Trong"
                            3 => "T&#46;C&#46; Van"
                            4 => "T&#46;T&#46; Minh"
                            5 => "P&#46;P&#46;T&#46; Minh"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.3889/oamjms.2019.054"
                      "Revista" => array:6 [
                        "tituloSerie" => "Open Access Maced J Med Sci&#46;"
                        "fecha" => "2019"
                        "volumen" => "7"
                        "paginaInicial" => "217"
                        "paginaFinal" => "220"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30745963"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "es"
  "url" => "/00017310/0000011300000001/v2_202202160543/S0001731021002854/v2_202202160543/es/main.assets"
  "Apartado" => array:4 [
    "identificador" => "92872"
    "tipo" => "SECCION"
    "es" => array:2 [
      "titulo" => "Foro de Residentes &#47; Resident&#39;s Forum"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "es"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/00017310/0000011300000001/v2_202202160543/S0001731021002854/v2_202202160543/es/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731021002854?idApp=UINPBA000044"
]
Article information
ISSN: 00017310
Original language: Spanish
The statistics are updated each day
Year/Month Html Pdf Total
2024 November 68 24 92
2024 October 470 143 613
2024 September 494 127 621
2024 August 560 153 713
2024 July 482 127 609
2024 June 510 120 630
2024 May 464 123 587
2024 April 422 112 534
2024 March 509 139 648
2024 February 623 119 742
2024 January 679 98 777
2023 December 528 76 604
2023 November 589 99 688
2023 October 545 102 647
2023 September 412 75 487
2023 August 459 71 530
2023 July 522 86 608
2023 June 454 75 529
2023 May 524 144 668
2023 April 474 102 576
2023 March 432 83 515
2023 February 304 114 418
2023 January 216 102 318
2022 December 255 100 355
2022 November 257 122 379
2022 October 266 140 406
2022 September 202 85 287
2022 August 224 105 329
2022 July 219 103 322
2022 June 220 86 306
2022 May 247 98 345
2022 April 216 99 315
2022 March 203 150 353
2022 February 257 138 395
2022 January 154 71 225
2021 December 93 50 143
2021 November 102 58 160
2021 October 158 92 250
2021 September 139 94 233
2021 August 136 80 216
2021 July 10 30 40
Show all

Follow this link to access the full text of the article

Idiomas
Actas Dermo-Sifiliográficas
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?